high) did not reach statistical significance either with overall (univariate: HR: 0.71; 95% CI: 0.28–1.76; multivariate: HR: 0.95; 95% CI: 0.28–3.20) or disease-free survival (univariate: HR: 0.9; 95% CI: 0.37–2.2; multivariate: HR: 1.29; 95% CI: 0.42–3.9) in CRC patients.
← all excerpts
Impact of Tumor <i>LINE-1</i> Methylation Level and Neoadjuvant Treatment and Its Association with Colorectal Cancer Survival.
1
—
—